NCT06120283 2026-04-15BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting399 enrolled
NCT04553133 2026-04-13PF-07104091 as a Single Agent and in Combination TherapyPfizerPhase 2 Active not recruiting157 enrolled